Actively Recruiting
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2026-01-16
60
Participants Needed
1
Research Sites
271 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.
CONDITIONS
Official Title
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Patients with peritoneal carcinosis awaiting cytoreductive surgery
- Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale
- Patients with sufficient command of the French language
- Patient affiliated to a French social security system
- Patient hospitalized at the Institute of cancer of Montpellier the day before cytoreductive surgery
- Signing of informed consent before any specific trial procedure
You will not qualify if you...
- Patients who already have daily practice of cardiac coherence
- Presence of proven psychiatric disorders such as mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, or receiving psychotic treatment that impairs thinking, judgment or discernment
- Physical or sensory inability to respond to questionnaires
- Patients who have had a heart transplant or bypass surgery in the year before surgery
- History of uncontrolled neurological pathology within the last 6 months before trial inclusion
- History of psychoactive substance dependence (excluding smoking) in the last 6 months before trial inclusion
- Patients with brain metastases
- Known natural bradycardia below 50 beats per minute
- Current beta-blocker intake
- Ongoing cardiac arrhythmias
- Known severe heart failure with ventricular ejection fraction below 40%
- Chronic uncontrolled pain making it difficult to practice the technique
- Patient with chronic obstructive pulmonary disease
- Legal incapacity such as guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICM
Montpellier, Hérault, France, 34298
Actively Recruiting
Research Team
J
Jean-Pierre BLEUSE, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here